Format

Send to

Choose Destination
See comment in PubMed Commons below
Adv Chronic Kidney Dis. 2015 May;22(3):211-7. doi: 10.1053/j.ackd.2014.12.004.

Obesity and insulin resistance in resistant hypertension: implications for the kidney.

Author information

1
Division of Nephrology and Hypertension, Department of Internal Medicine, University of Missouri-Columbia School of Medicine, Columbia, MO; and Harry S. Truman Memorial Veterans Hospital. Electronic address: raoak@health.missouri.edu.
2
Division of Nephrology and Hypertension, Department of Internal Medicine, University of Missouri-Columbia School of Medicine, Columbia, MO; and Harry S. Truman Memorial Veterans Hospital.

Abstract

There is recognition that the obesity epidemic contributes substantially to the increasing incidence of CKD and resistant hypertension (HTN). The mechanisms by which obesity promotes resistance are an area of active interest and intense investigation. It is thought that increases in visceral adiposity lead to a proinflammatory, pro-oxidative milieu that promote resistance to the metabolic actions of insulin. This resistance to insulin at the level of skeletal muscle tissue impairs glucose disposal/utilization through actions on the endothelium that include vascular rarefaction, reductions in vascular relaxation, and vascular remodeling. Insulin resistance derived from increased adipose tissue and obesity has system-wide implications for other tissue beds such as the kidney that affects blood pressure regulation. The additional autocrine and paracrine activities of adipose tissue contribute to inappropriate activation of the renin-angiotensin-aldosterone system and the sympathetic nervous system that promote kidney microvascular remodeling, stiffness, and sodium (Na(+)) retention that in turn promote HTN and in the CKD patient, resistance. In this review, we will summarize the important mechanisms that link obesity to CKD as they relate to resistant HTN.

KEYWORDS:

Endothelial dysfunction; Hypertension; Insulin resistance; Obesity; RAAS

PMID:
25908470
DOI:
10.1053/j.ackd.2014.12.004
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center